[HTML][HTML] Comparing computer-generated and pathologist-generated tumour segmentations for immunohistochemical scoring of breast tissue microarrays
British Journal of Cancer, 2015•nature.com
Background: Tissue microarrays (TMAs) have become a valuable resource for biomarker
expression in translational research. Immunohistochemical (IHC) assessment of TMAs is the
principal method for analysing large numbers of patient samples, but manual IHC
assessment of TMAs remains a challenging and laborious task. With advances in image
analysis, computer-generated analyses of TMAs have the potential to lessen the burden of
expert pathologist review. Methods: In current commercial software computerised oestrogen …
expression in translational research. Immunohistochemical (IHC) assessment of TMAs is the
principal method for analysing large numbers of patient samples, but manual IHC
assessment of TMAs remains a challenging and laborious task. With advances in image
analysis, computer-generated analyses of TMAs have the potential to lessen the burden of
expert pathologist review. Methods: In current commercial software computerised oestrogen …
Abstract
Background:
Tissue microarrays (TMAs) have become a valuable resource for biomarker expression in translational research. Immunohistochemical (IHC) assessment of TMAs is the principal method for analysing large numbers of patient samples, but manual IHC assessment of TMAs remains a challenging and laborious task. With advances in image analysis, computer-generated analyses of TMAs have the potential to lessen the burden of expert pathologist review.
Methods:
In current commercial software computerised oestrogen receptor (ER) scoring relies on tumour localisation in the form of hand-drawn annotations. In this study, tumour localisation for ER scoring was evaluated comparing computer-generated segmentation masks with those of two specialist breast pathologists. Automatically and manually obtained segmentation masks were used to obtain IHC scores for thirty-two ER-stained invasive breast cancer TMA samples using FDA-approved IHC scoring software.
Results:
Although pixel-level comparisons showed lower agreement between automated and manual segmentation masks (κ= 0.81) than between pathologists’ masks (κ= 0.91), this had little impact on computed IHC scores (Allred;= 0.91, Quickscore;= 0.92).
Conclusions:
The proposed automated system provides consistent measurements thus ensuring standardisation, and shows promise for increasing IHC analysis of nuclear staining in TMAs from large clinical trials.
nature.com